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Calcemic response to parathyroid hormone in renal failure: Role of
calcitriol and the effect of parathyroidectomy. Hyperparathyroidism due
to renal failure begins in the early stages of renal insufficiency and is in
part secondary to skeletal resistance to the calcemic action of parathy-
roid hormone (PTH). Factors which have been reported to reduce the
calcemic response to PTH include: decreased calcitriol levels, hyper-
phosphatemia and down regulation of PTH receptors in bone. While
hyperphosphatemia may directly decrease the calcemic response to
PTH, it may also act indirectly by a suppression of calcitriol synthesis.
In this study, the effect of calcitriol on the calcemic response to PTH
was evaluated in normal rats and in rats with moderate and advanced
renal failure. To determine the combined effect of calcitriol and
phosphorus on the calcemic response to PTH, rats receiving calcitriol
were fed either a high (1.0%) or low (0.2%) phosphorus diet during a
48-hour PTH infusion. In advanced renal failure, calcitriol administra-
tion increased the calcemic response to PTH independent of the dietary
phosphorus intake. During ingestion of a low phosphorus diet, a 48 hour
PTH infusion resulted in a serum calcium level of 13.7 0.5 and 12.1
0.2 mg/dl (P < 0.02) with and without calcitriol administration, respec-
tively. In normal rats and in rats with moderate renal failure, calcitriol
administration improved the calcemic response only during a high
phosphorus intake. After a 48-hour PTH infusion in normal rats, the
serum calcium levels with and without calcitriol were 16.1 0.9 and
14.8 0.6 mg/dl, P < 0.01 respectively; in rats with moderate renal
failure, calcitriol administration increased serum calcium, 13.2 0.5
versus 11.2 0.4 mgldl, P <0.01. Since calcitriol administration and a
low phosphorus diet improved but did not normalize the calcemic
response to PTH, a selective parathyroidectomy was performed to
eliminate the effect of down regulation of bone receptors for PTH
induced by high PTH levels. Whereas calcitriol increased the calcemic
response by only 31%, parathyroidectomy corrected the calcemic
response to PTH even in the presence of renal failure. In conclusion,
the effect of calcitriol administration on the calcemic response to PTH
is modified by the magnitude of phosphate retention and the degree of
renal failure. Finally, the finding that parathyroidectomy normalized the
calcemic response to PTH in azotemic rats suggests that a high FF11
level is an essential factor in the impaired calcemic response to PTH in
renal failure.
Hyperparathyroidism is a common finding in patients with
renal failure [1, 2]. Skeletal resistance to the calcemic action of
PTH in renal failure is considered to be an important factor in
the development of secondary hyperparathyroidism [3]. Fac-
tors which may play a role in the skeletal resistance to PTH
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include phosphorus retention [4], low calcitriol levels [5, 6] and
down regulation of bone receptors to PTH [7].
Dietary phosphorus restriction ameliorates secondary hyper-
parathyroidism [8, 9]. Several mechanisms may mediate this
effect [10—13]; one is an improvement in the calcemic response
to PTH [11]. Such an improvement may be due to a decrease in
the serum phosphorus level and an increase in the calcitriol
level associated with phosphorus restriction.
We have recently shown in rats with moderate and advanced
renal failure, that control of serum phosphorus by dietary
phosphorus restriction improved the calcemic response to PTH
[14]. In that study, phosphorus restriction was associated with
an increase in the serum calcitriol level in moderate but not in
advanced renal failure rats. Thus, the increase in serum cal-
citriol may be in part responsible for the improvement in the
calcemic response to PTH in moderate renal failure.
Although there is considerable evidence to support calcitriol
deficiency as a factor in the skeletal resistance to the calcemic
action of PTH, there is not uniform agreement. Massry et al
observed that calcitriol administration improved the calcemic
response to PTH in dogs with acute and chronic renal failure [5,
6]. Similar results were observed by others in both dogs and rats
with chronic renal failure [15, 16]. In contrast, other investiga-
tors have not been able to confirm these results. Galceran et al
[7] noted that calcitriol did not improve the calcemic response
to PTH in dogs with chronic renal failure. However, the
removal of circulating PTH by thyroparathyroidectomy did
correct the calcemic response to PTH; this suggested that down
regulation of PTH receptors was a key factor in the decreased
calcemic response to PTH.
The above-mentioned studies on the calcemic response to
PTH were not designed to separate the effect of calcitriol from
that of phosphorus. In advanced renal failure, phosphorus
retention may directly decrease the calcemic response to PTH
and obscure any beneficial effect of calcitriol administration; on
the other hand, in early or moderate renal failure, a beneficial
effect of calcitriol administration may be observed only if
calcitriol levels are depressed as a consequence of phosphorus
retention.
The aim of the present investigation was to evaluate the effect
of calcitriol administration on the calcemic response to PTH in
rats with different degrees of renal function impairment. This
was evaluated in the presence of both high and low serum
phosphorus levels. Thus, the effect of calcitriol could be sepa-
rated from that of phosphorus. In addition, the effect of
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parathyroidectomy on the calcemic response to PTH in renal
failure was also evaluated.
Methods
Male Wistar rats weighing 125 to 140 grams were divided into
three groups: the first group underwent sham operation, the
second group ligation of one main artery in the hilum of the left
kidney, followed one week later by right nephrectomy; and the
third group had ligation of two main arteries in the hilum of the
left kidney, followed one week later, by right nephrectomy. The
purpose was to produce different degrees of renal failure.
After the right nephrectomy, all rats were placed on a diet
containing 0.6% calcium and 1.2% phosphorus with 100 IU/lOO
g of vitamin D. The excess of phosphorus in the diet was
obtained by adding equal amounts of sodium and potassium
phosphate. This high phosphorus diet has been shown to
promote secondary hyperparathyroidism in rats with renal
failure [17, 181. All rats were maintained in individual cages and
ingested similar amount of food which ranged from 12 to 14
grams; rats ingesting less than 12 grams per day were removed
from the study. Seventeen days after the initiation of the high
phosphorus diet, blood was obtained for measurement of cre-
atinine, phosphorus, calcium, and PTH. Rats were separated
according to their serum creatinine concentration and assigned
to one of the following groups: Normal renal function, serum
creatinine less than 0.5 mg/dl, (serum PTH: 43 7 pg/mi);
Moderate renal failure, serum creatinine between 0.5 and 0.6
mg/dl, (serum PTH: 83 16 pg/mI); and Advanced renal failure,
serum creatinine greater than 0.6 mg/dl, (serum PTH: 229 21
pg/ml).
Twenty days after the right nephrectomy, rats were fasted for
12 hours and then PTH was infused. Rat 1-34 PTH, (Bachem,
Torrance, California, USA) from a single lot was infused at 2.5
U/100 g body weight/hr for 48 hours via a subcutaneously
implanted miniosmotic pump (AIza, Palo Alto, California,
USA, model 2001). The pumps were filled with PTH in isoos-
motic saline with 2% cysteine HCI (pH 1.5) and placed in a bath
with normal saline at 37°C for four hours prior to implantation
in the rat. Blood for calcium, phosphorus and creatinine was
obtained immediately before the placement of the miniosmotic
pump, and after 24 and 48 hours. During the PTH infusion, rats
were maintained in individual metabolic cages and urine was
collected for measurement of volume, calcium, and creatinine.
Since the miniosmotic pump maintains a constant delivery of
one microliter per hour and the filling volume was 200 microli-
ters, its functional life-span was at least seven days. After a 48
hour infusion, each pump was removed and implanted in a
similar weight rat from a different group; thus, the same pump
was used in a random order in a different group of rats. Each
pump was not used in more than three rats (6 days).
Effect of ca/curio! administration
During the morning of the first and second day of PTH
administration, each rat received intraperitoneal calcitriol (40
ng/lOO g) or vehicle. This dose of calcitriol has produced levels
of 400 to 600 pg/mi 24 hours after administration (measured by
radioreceptor assay after column separation, Nichols Institute,
San Juan Capistrano, California, USA); these levels are similar
to serum calcitriol levels observed in a normal rat stimulated
with the same dose of PTH and fed a low phosphorus diet. The
effect of calcitriol on the calcemic response to PTH may be
modified by the level of serum phosphorus; thus, at the time of
PTH infusion, the diet was changed to either a low phosphorus,
P:0.2% (LPD) or a high phosphorus diet, P: 1.0% (HPD). To
minimize differences resulting from gastrointestinal absorption
of calcium, the calcium content of the diet was reduced to a
negligible amount (0.01%). To obtain a 1% phosphorus diet,
phosphorus was added as sodium and potassium phosphate.
Some of the control rats in this study were included in a
previous study which evaluated the effect of dietary phosphorus
on the calcemic response to PTH [141.
Effect of parathyroidectomy
Twenty-seven rats underwent selective parathyroidectomy
(PTX) at the time of either sham operation or artery ligation of
the left kidney. To validate the effectiveness of PTX, these rats
were maintained on a diet of 0.6% calcium and 0.6% phospho-
rus for three days; blood was then obtained and only rats with
serum calcium levels less than 7 mg/dl were included. These
rats were fed a diet containing the same caloric content as the
other groups but to prevent severe hypocalcemia this diet
contained 0.8% phosphorus and 1.2% calcium until the day of
the PTH infusion. Twenty days after nephrectomy, these rats
underwent a PTH infusion as described above and received a
LPD during the PTH infusion.
Serum calcium was measured by atomic absorption (Perkin
Elmer, Norwalk, Connecticut, USA), serum phosphorus with a
specific kit (Sigma Chemical Co., St. Louis, Missouri, USA);
serum creatinine with a creatinine analyzer (Beckman Instru-
ments, Fullerton, California, USA); serum PTH with an N-ter-
minal radioimmunoassay (Nichols Institute). This assay has
been previously validated for the determination of circulating
PTH in the rat 118—20].
Analysis of variance (ANOVA) was followed by the Dun-
can's test to compare means from the same group of rats. The
unpaired t-test was used for the comparison of the means
between two different groups. A multiple regression analysis
was performed to correlate the caicemic response to PTH with
the serum creatinine, serum phosphorus and the administration
of caicitriol. Results are expressed as mean standard error
(SE).
Results
Effect of calcitriol administration
Low phosphorus diet. The effect of calcitriol administration
on the calcemic response to PTH in rats fed a LPD is shown in
Figure 1. Calcitriol administration to normal rats on a LPD did
not change the calcemic response to PTH. After 48 hours of a
PTH infusion, rats receiving calcitriol had serum calcium levels
of 17.4 0.5 versus 18.2 0.5 mg!dl (NS) in rats without
calcitriol supplementation. Serum levels of phosphorus were
not affected by the administration of calcitriol in this group.
In rats with moderate renal failure ingesting a LPD, the
administration of calcitriol produced results similar to those in
normal rats; however, the overall calcemic response to PTH
was less than in normal rats. At 48 hours, the serum calcium
level was not significantly different in the group receiving
calcitriol, 15.1 1 versus 13.7 0.9 mg/dl in the group without
Eo '-.
a
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Fig. 1. Changes in the serum level of calcium
and phosphorus during 48 hours of a continuous
PTH infusion are shown in normal rats, (A) Cr <
0.5 mg/dl; rats with moderate renal failure, (B)
Cr:0.5—0.6 mg/dl and rats with advanced renal
failure, (C) Cr> 0.6 mgldl. During the PTH
infusion rats were fed a low (0.2%) phosphorus
diet and minimal calcium (0.01%). The
interrupted line indicates a daily calcitriol
administration of 40 ngIlOO g. The continuous line
represents rats receiving vehicle. (*) P < 0.05.
Table 1. Total urinary excretion of calcium (mg), during the 48 hours of PTH infusion in rats receiving either vehicle (veh) or calcitriol (CTR)
LPD HPD
Scr <0.5 0.5—0.6 >0.6 <0.5 0.5—0.6 >0.6
veh
N
CTR
N
8.7 3.0
11
11.8 2.5
8
4.3 1.3
9
4.6 0.6
7
2.8 0.5
21
2.5 0.6
12
1.7 0.4
12
3.7 1.5
7
1.3 0.2
13
2.9 0.6a
Il
1.1 0.2
8
0.7 0.2
7
Abbreviations are: Scr, serum creatinine (mg/dl); LPD, low phosphorus diet (P = 0.2%, Ca = 0%); HPD, high phosphorus diet (P = 1.0%, Ca
0%); N, number of animals.
a P < 0.05 as compared with veh
calcitriol administration. Serum levels of phosphorus did not
change with calcitriol administration.
In advanced renal failure, the administration of calcitriol did
not change the serum phosphorus level but did significantly
increase the calcemic response to PTH. After 48 hours of a PTH
infusion, the serum level of calcium with and without calcitriol
supplementation was 13.7 0.5 versus 12.1 0.2 mg/dl (P <
0.02), respectively.
On the LPD, urinary calcium excretion was similar in rats
with and without calcitriol administration (Table I).
High phosphorus diet
On a HPD, calcitriol administration improved the calcemic
response to PTH in all three groups (Fig. 2). In normal rats,
calcitriol supplementation increased the serum calcium level at
24 hours, from 11.0 0.1 to 12.2 0,2 mg/dl, P <0.001 and at
48 hours of PTH administration, from 14,8 0.6 to 16.1 0.9
mgldl, P <0.01. These differences were observed despite no
significant difference in the level of serum phosphorus.
In moderate renal failure, the calcemic response to PTH at 48
hours was increased in rats receiving calcitriol (serum calcium,
13.2 0.5 vs. 11.2 0.4 mg/dl, P < 0.01). The serum level of
phosphorus was not increased by calcitriol administration.
In advanced renal failure, the administration of calcitriol
increased the calcemic response to PTH at 48 hours (serum
calcium, 11.4 0.3 vs. 9.6 0.5 mg/dl, P < 0.01). This result
was observed despite a higher serum phosphorus level in the
rats receiving calcitriol (18.5 2 vs. 12.3 1.4 mg/dl, P <
0.02).
The improved calcemic response produced by calcitriol ad-
ministration during HPD was accompanied by increased uri-
nary excretion of calcium (Table 1). Thus, the differences in
serum calcium could not be attributed to a decrease in the renal
excretion of calcium.
Effect of parathyroidectomy
The effect of parathyroidectomy on the calcemic response to
PTH was evaluated in three groups of rats with different levels
of renal function (Fig. 3). All groups received a LPD during the
PTH infusion. Parathyroidectomized rats were compared with
parathyroid intact rats which are presented in Figure 1 as
controls.
In parathyroidectomized rats with normal renal function, the
serum calcium concentration at 48 hours increased to 17.6 0.7
mg/dl, despite an initial baseline serum calcium level of 7.3
0.8 mgldl; this value was similar to that observed in parathyroid
intact rats with normal renal function, 18.2 0.4 mgldl. In the
PTX group, the baseline serum phosphorus was greater, 12.3
0.7 versus 7.8 0.2 mgldl, P < 0.001, but no differences were
observed after 48 hours of PTH infusion.
In moderate renal failure, PTX increased the calcemic re-
sponse to PTH. The serum calcium increased to 17.1 0.8
A Cr < 0.5 B Cr = 0.5-0.6
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mg/dl at 48 hours as compared with 13.7 0.9 mgldl (P < 0.001)
in the non-PTX rats. There were no differences in serum
phosphorus at 24 and 48 hours.
In advanced renal failure, PTX also increased the calcemic
response to PTH. The serum calcium level at 48 hours was 16.5
0.4 mgldl; this was significantly greater than that observed in
the parathyroid intact rat, 12.0 0.2 mg/dl, P < 0.001. This
result was observed despite a serum phosphorus level at 48
hours that was significantly higher in the PTX rat than in the
intact rat, 8.5 0.6 versus 6.7 0.3 mg/dl, P < 0.02,
In PTX rats, the serum calcium concentration after 48 hours
of PTH infusion was not different between the three groups.
Thus parathyroidectomy corrected the effect of renal failure on
the calcemic response to PTH.
A multiple regression analysis was performed to correlate the
calcemic response with the serum creatinine, serum phospho-
Fig. 2. Changes in the serum level of calcium
and phosphorus during 48 hours of a continuous
PTH infusion are shown in normal rats, (A) Cr <
0.5 mg/dl; rats with moderate renal failure, (B)
Cr:0.5—0.6 mg/dl and rats with advanced renal
failure, (C) Cr> 0.6 mg/dl. During the PTH
infusion, rats were fed a high (1.0%) phosphorus
diet and minimal calcium (0.01%). The
interrupted line indicates a daily calcitriol
administration of 40 ng/100 g. The continuous line
represents rats receiving vehicle. (*) P < 0.05.
Fig. 3. Changes in the serum level of calcium
and phosphorus during 48 hours of a continuous
PTH infusion are shown in normal rats, (A) Cr <
0.5 mg/dl; rats with moderate renal failure, (B)
Cr:0.5—O.6 mg/dl and rats with advanced renal
failure, (C) Cr > 0.6 mg/dl. During the P'I'H
infusion rats were fed a low (0.2%) phosphorus
diet and minimal calcium (0.01%). The
interrupted line indicates rats with
parathyroidectomy (PTX), and the continuous
line represents parathyroid intact rats (same as
the controls in Fig. 1). (*) P < 0.05.
rus and administration of calcitriol. Using this model, the
calcemic response was found to be reduced by 61% due to an
increased serum creatinine level and reduced by 39% due to an
increased serum phosphorus concentration. The administration
of calcitriol reversed by 31% the combined negative effect of
increased serum phosphorus and creatinine levels (Fig. 4).
Parathyroidectomy corrected the calcemic response.
Discussion
The results of this study showed that calcitriol did improve
the calcemic response to PTH in renal failure and this effect wa
modified by dietary phosphorus. Removal of circulating PTH
by parathyroidectomy normalized the calcemic response to
PTH even in the presence of renal failure, suggesting that down
regulation of PTH bone receptors is an essential factor,
In advanced renal failure, calcitriol improved the calcemic
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Fig. 4. The effect of renal failure, phosphorus retention, calcitriol
administration and PTX on the calcemic response to PTH. Values were
calculated from a mathematical formula which was obtained from
multiple regression analysis: Y = 2.982 — 0.031 (±0.0028) X1 — 0.349
(±0.037) X2 + 0.119 (±0.02) X3 with a correlation coefficient of r =
0.803, P < 0.00001; whereas y = log of serum calcium concentration
after 48 hours of PTH infusion, X1 is the serum phosphorus in mg, X2
is the serum creatinine in mg, and X3 is 2 or 1, depending on whether
calcitriol was administered or not, respectively. For the purpose of this
statistical analysis, serum calcium concentration was expressed as a
logarithm and the administration of calcitriol was given a value of two
and administration of vehicle a value of one. Using this model the
calcemic response was found to be reduced by 61% due to an increase
in serum creatinine level (>0.6 mg/dl) and reduced an additional 39%
due to a dietary induced increase in serum phosphorus. The adminis-
tration of calcitriol reversed by 31% the combined negative effect of
increased serum phosphorus and creatinine. Parathyroidectomy cor-
rected the calcemic response.
response both during a low and high phosphorus diet. In normal
rats and in rats with moderate renal failure, this beneficial effect
of calcitriol was observed only during a high phosphorus diet.
Previous reports have shown that calcitriol improved the cal-
cemic response to VFH in renal failure [5, 6, 15, 16, 211, a
condition in which calcitriol levels are low [22—241. Since in
moderate renal failure, a high phosphorus diet reduced serum
calcitriol levels [101, the replacement of calcitriol in these rats
may increase the calcemic response to PTH.
The administration of calcitriol to rats on a LPD improved the
calcemic response to PTH only in rats with advanced renal
failure. This effect of calcitriol could not be attributed to
differences in the serum phosphorus concentration. When rats
were placed on a HPD which resulted in an increase in serum
phosphorus, calcitriol administration increased the calcemic
response to PTH in normals rats, and rats with moderate and
advanced renal failure. However, except in the group with
normal renal function, the effect of calcitriol administration was
not observed until the second day of PTH infusion. Previous
studies have shown that calcitriol improved the calcemic re-
sponse to PTH in animals with renal failure, a condition in
which hyperphosphatemia is generally observed. In TPTX dogs
with acute renal failure due to bilateral nephrectomy, Massry et
a! [5, 6] observed that the administration of calcitriol increased
the calcemic response to PTH. In chronic uremic dogs with
secondary hyperparathyroidism and hyperphosphatemia, Kap-
lan et al [15] also noted that calcitriol administration improved
the calcemic response to PTH. Similar results were obtained by
Jacob et a! [21]. Somerville and Kaye [16] observed that
calcitriol improved the calcemic response to PTH in rats with
chronic renal failure but not with acute renal failure. Our
presumption is that when levels of calcitriol are reduced due to
a decrease in renal mass and/or hyperphosphatemia, the admin-
istration of calcitriol improves the calcemic response to PTH;
our results would suggest that when the serum level of calcitriol
is normal, additional calcitriol does not further increase the
calcemic response to PTH.
In patients with moderate renal failure, Llach and Massry
[11] observed that phosphorus restriction reduced hyperpara-
thyroidism, increased plasma calcitriol levels and improved the
calcemic response to PTH. Both phosphorus restriction and the
increase in plasma calcitriol may have been responsible for the
improved calcemic response to PTH. However, since phospho-
rus restriction resulted in reduced PTH levels, less down
regulation of bone receptors for PTH may have also played a
role.
Other investigators have reported that calcitriol administra-
tion did not improve the calcemic response to PTH. Galceran et
a! [7] observed that seven days of calcitriol administration to
chronic uremic dogs did not change the calcemic response to a
six-hour PTH infusion; our results would suggest that a more
prolonged infusion of PTH may be necessary to show differ-
ences.
Our data show that calcitriol administration improved but did
not completely correct the calcemic response to PTH. Thus, in
addition to the effect of a high serum phosphorus and a low
calcitriol level, there was still a defect in the calcemic response
to PTH that was only corrected after parathyroidectomy;
hence, as suggested by Galceran et al [7], high PTH levels
appear to down regulate bone PTH receptors and prevent
complete restoration of the calcemic response to PTH. Our
experimental design was somewhat different than that of Ga!-
ceran et a!. We evaluated the effect of selective PTX on the
calcemic response to PTH in rats with the same degree of renal
function. The results of our study confirmed that in the absence
of circulating PTH, renal failure did not decrease the calcemic
response to PTH. These results suggest that persistently high
PTH levels desensitize the bone to the calcemic action of PTH.
In addition, our data show that PTX rats with normal renal
function did not have a greater calcemic response to PTH than
parathyroid-intact rats with normal renal function; thus, it
would appear that normal circulating levels of PTH do not down
regulate PTH receptors in bone.
Although removal of the parathyroid gland restored the
calcemic response to PTH, this does not exclude an important
role of other factors such as hyperphosphatemia and a calcitriol
deficiency (Fig. 4). Both factors are present in renal failure and
are involved in the generation of secondary hyperparathyroid-
ism. A decrease in the calcemic response to PTH could be one
of the mechanisms by which these two factors contribute to the
generation of secondary hyperparathyroidism in renal failure.
In conclusion, in rats with moderate and advanced renal
failure, there was a decreased calcemic response to PTH. The
reduction in the calcemic response to PTH correlated with the
degree of renal failure, but PTX restored the calcemic response
to PTH. These findings suggest that down regulation of bone
receptors to PTH is an essential factor in the impaired calcemic
response to PTH. Both the level of serum phosphorus and the
administration of calcitriol modulated the calcemic response to
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PTH. The beneficial effect of calcitriol was observed in ad-
vanced renal failure and during a high phosphorus diet at any
level of renal function.
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